Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2008 Nov;8(11):865-73. doi: 10.1038/nrc2502. Epub 2008 Oct 16.

The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer.

Author information

1
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815-6789, USA. William_Kaelin@dfci.harvard.edu

Abstract

The von Hippel-Lindau disease is caused by inactivating germline mutations of the VHL tumour suppressor gene and is associated with an increased risk of a variety of tumours in an allele-specific manner. The role of the heterodimeric transcription factor hypoxia-inducible factor (HIF) in the pathogenesis of VHL-defective tumours has been more firmly established during the past 5 years. In addition, there is now a greater appreciation of HIF-independent VHL functions that are relevant to tumour development, including maintenance of the primary cilium, regulation of extracellular matrix formation and turnover, and modulation of cell death in certain cell types following growth factor withdrawal or in response to other forms of stress.

PMID:
18923434
DOI:
10.1038/nrc2502
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center